HHealth Read More An approved Ebola antibody may miss its mark against Bundibugyo virusSeptember 29, 2026 Antibodies developed for one Ebola virus species face a different viral target in the 2026 outbreak. Structural models…
HHealth Read More Blood test detects more cancers when added to standard screeningSeptember 23, 2026 A single blood draw that screens for more than 50 cancers substantially increased cancer detection when added to…
HHealth Read More Digital companion apps help secure long-term habits during GLP-1 therapySeptember 9, 2026 Glucagon-like peptide-1 (GLP-1) medications have revolutionized weight management, yet high dropout rates and rapid weight regain remain significant…
HHealth Read More Targeting cyclin-dependent kinases offers new pathways for cancer therapyAugust 24, 2026 Cancer is the second leading cause of death in Germany. In the search for new therapeutic approaches that…
HHealth Read More Scientists map key differences in stem cell potency for treating knee osteoarthritisAugust 7, 2026 Knee osteoarthritis (KOA) affects more than 1 in 10 people over 40 years of age, impairing patients’ mobility…
SScience Read More Structured setup drives patient engagement with virtual reality therapyJuly 7, 2026 A new study published in JMIR XR and Spatial Computing demonstrates that the way virtual reality therapeutics (VRx)…
MMedication Read More NAFDAC warns Nigerians as US recalls children’s ibuprofen over contamination concernsJune 15, 2026 The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted healthcare providers, importers, distributors and…
HHealth Read More New digital platform treats insomnia and anxiety in seniorsJune 9, 2026 Cognitive behavioral therapies for insomnia (CBT-I) are increasingly being delivered online in order to improve accessibility. However, although…
HHealth Read More Wholegrain rye changes gut bacteria and lowers inflammation in obesity trialMarch 25, 2026 A 12-week randomized trial found that wholegrain rye did not beat refined wheat for weight loss, but it…
HHealth Read More Oral semaglutide fails to slow early Alzheimer’s decline in two phase 3 trialsMarch 23, 2026 Despite hopes raised by earlier observational studies and biomarker shifts, The Lancet trials found that oral semaglutide did…
HHealth Read More Largest review finds no mental health benefits of medicinal cannabisMarch 17, 2026 A landmark Lancet Psychiatry paper published today – the largest-ever review of the safety and efficacy of cannabinoids across a range…
HHealth Read More Remote ischemic conditioning shields the heart from chemotherapy damageMarch 2, 2026 Advances in cancer treatment mean that more people than ever are surviving the disease. However, some of the…